Bli medlem
Bli medlem

Du är här

2016-05-10

GLOBAL BIOENERGIES: Scale up of the Isobutene process has been demonstrated

GLOBAL BIOENERGIES
: Scale up of the Isobutene process
has been demonstrated

Evry (France), 10 May, 2016 -
Global Bioenergies (Alternext Paris: ALGBE) announces that the performance
obtained in 2015 at laboratory scale has now been successfully reproduced in
the pilot unit installed in Pomacle-Bazancourt (eastern France).

During the last fermentation-trial series, up to 74% of commercial target
yield has been achieved. In addition, a high yield (higher than 65% of
target) was maintained over several days. Strong robustness of the process is
a key parameter for exploitation at larger scale.

Global Bioenergies' Isobutene process is the first-of-a-kind technology to
directly produce a gas by fermentation. These results factually demonstrate
that the process scales up very well at this stage. The demo plant, presently
under construction in Germany, will allow running the technology at ton scale
within months.

Marc Delcourt, co-founder and CEO of Global Bioenergies, concludes: "While our
technology comes closer to commercial performances, the oil market is now
swinging back. Innovative solutions to produce fuels and materials are more
necessary today than ever. Global Bioenergies is getting prepared to play an
important role in the transition of the energy and chemistry worlds toward
technologies more friendly to the environment."

About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in
Europe, that is developing a process to convert renewable resources into
hydrocarbons through fermentation. The Company initially focused its efforts
on the production of isobutene, one of the most important petrochemical
building blocks that can be converted into fuels, plastics, organic glass and
elastomers. Global Bioenergies continues to improve the performances of its
process, operates its industrial pilot, has begun the construction of its
demo plant in Germany, and prepares the first full-scale plant through a
Joint-Venture with Cristal Union, named IBN-One. The company also replicated
its achievement to propylene and butadiene, two members of the gaseous
olefins family, key molecules at the heart of petrochemical industry. Global
Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE).

Should you like to be kept informed, subscribe to our news feed on

www.global-bioenergies.com

Follow us on Twitter:
@GlobalBioenergi

Contact

GLOBAL BIOENERGIES

Thomas BUHL
Head of Business Development
Phone: +33 (0)1 64 98 20 50
Email:thomas.buhl@global-bioenergies.com

----
| |
| |
----
PRESS RELEASE
http://hugin.info/166909/R/2011379/744620.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GLOBAL BIOENERGIES via Globenewswire

HUG#2011379

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.